Titin: Central player of hypertrophic signaling and sarcomeric protein quality control

Biological Chemistry

Volumn 395, Issue 11, 2014, Pages 1341-1352

  Kötter, Sebastian ^a   Andresen, Christian ^a   Krüger, Martina ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Chaperones; connectin; heat shock proteins

Indexed keywords

CHAPERONE; CONNECTIN;

ARTICLE; HUMAN; MECHANOTRANSDUCTION; MUSCLE HYPERTROPHY; NONHUMAN; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN QUALITY; PROTEIN STRUCTURE; QUALITY CONTROL; SARCOMERE; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; METABOLISM; PROTEIN CONFORMATION;

ANIMALS; CONNECTIN; HUMANS; MECHANOTRANSDUCTION, CELLULAR; MOLECULAR CHAPERONES; PROTEIN CONFORMATION; SARCOMERES; SIGNAL TRANSDUCTION;

EID: 84907651987     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2014-0178     Document Type: Article

References (125)

1. Ahmad, M.F., Raman, B., Ramakrishna, T., and Rao, C.M. (2008). Effect of phosphorylation on alpha B-crystallin: differences in stability, subunit exchange and chaperone activity of homo and mixed oligomers of alpha B-crystallin and its phosphorylationmimicking mutant. J. Mol. Biol. 375, 1040-1051.
2. Alegre-Cebollada, J., Kosuri, P., Giganti, D., Eckels, E., Rivas-Pardo, J.A., Hamdani, N., Warren, C.M., Solaro, R.J., Linke, W.A., and Fernández, J.M. (2014). S-glutathionylation of cryptic cysteines enhances titin elasticity by blocking protein folding. Cell 156, 1235-1246.
3. Ali, M.A., Cho, W.J., Hudson, B., Kassiri, Z., Granzier, H., and Schulz, R. (2010). Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury. Circulation 122, 2039-2047.
4. Arber, S., Hunter, J.J., Ross, J. Jr., Hongo, M., Sansig, G., Borg, J., Perriard, J.C., Chien, K.R., and Caroni, P. (1997). MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 88, 393-403.
5. Attaix, D., Ventadour, S., Codran, A., Béchet, D., Taillandier, D., and Combaret, L. (2005). The ubiquitin-proteasome system and skeletal muscle wasting. Essays Biochem. 41, 173-186.
6. Avner, B.S., Shioura, K.M., Scruggs, S.B., Grachoff, M., Geenen, D.L., Helseth, D.L. Jr., Farjah, M., Goldspink, P.H., and Solaro, R.J. (2012). Myocardial infarction in mice alters sarcomeric function via post-translational protein modification. Mol. Cell Biochem. 363, 203-215.
7. Bang, M.L., Centner, T., Fornoff, F., Geach, A.J., Gotthardt, M., Mc-Nabb, M., Witt, C.C., Labeit, D., Gregorio, C.C., Granzier, H., et al. (2001). The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system. Circ. Res. 89, 1065-1072.
8. Barbato, R., Menabò, R., Dainese, P., Carafoli, E., Schiaffino, S., and Di Lisa, F. (1996). Binding of cytosolic proteins to myofibrils in ischemic rat hearts. Circ. Res. 78, 821-828.
9. Boateng, S.Y., Senyo, S.E., Qi, L., Goldspink, P.H., and Russel, B. (2009). Myocyte remodeling in response to hypertrophic stimuli requires nucelocytoplasmic shuttling of muscle LIM protein. J. Mol. Cell Cardiol. 47, 426-435.
10. Bullard, B., Ferguson, C., Minajeva, A., Leake, M.C., Gautel, M., Labeit, D., Ding, L., Labeit, S., Horwitz, J., Leonard, K.R., et al. (2004). Association of the chaperone áB-crystallin with titin in heart muscle. J. Biol. Chem. 279, 7917-7924.
11. Buyandelger, B., Ng, K.E., Miocic, S., Piotrowska, I., Gunkel, S., Ku, C.H., and Knöll, R. (2011). MLP (muscle LIM protein) as a stress sensor in the heart. Pflüger's Arch. 462, 135-142.
12. Candasamy, A.J., Haworth, R.S., Cuello, F., Ibrahim, M., Aravamudhan, S., Krüger, M., Holt, M.R., Terracciano, C.M., Mayr, M., Gaute, l.M., et al. (2014). Phosphoregulation of the titin-cap protein telethonin in cardiac myocytes. J. Biol. Chem. 289, 1282-1293.
13. Carrier, L., Schlossarek, S., Willis, M.S., and Eschenhagen, T. (2010). The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy. Cardiovasc. Res. 85, 330-338.
14. Centner, T., Yano, J., Kimura, E., McElhinny, A.S., Pelin, K., Witt, C.C., Bang, M.L., Trombitas, K., Granzier, H., Gregorio, C.C., et al. (2003). Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. J. Mol. Biol. 306, 717-726.
15. Chuderland, D. and Seger, R. (2005). Protein-protein interactions in the regulation of the extracellular signal-regulated kinase. Mol. Biotechnol. 29, 57-74.
16. Coulis, G., Becila, S., Herrera-Mendez, C.H., Sentandreu, M.A., Raynaud, F., Richard, I., Benyamin, Y., and Ouali, A. (2008). Calpain 1 binding capacities of the N1-line region of titin are significantly enhanced by physiological concentrations of calcium. Biochemistry 47, 9174-9183.
17. da Silva-Lopes, K., Pietas, A., Radke, M.H., and Gotthardt, M. (2011). Titin visualization in real time reveals an unexpected level of mobility within and between sarcomeres. J. Cell Biol. 193, 785-798.
18. Depre, C., Wang, Q., Yan, L., Hedhli, N., Peter, P., Chen, L., Hong, C., Hittinger, L., Ghaleh, B., Sadoshima, J., et al. (2006). Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy. Circulation 114, 1821-1828.
19. Diehl, F., Brown, M.A., van Amerongen, M.J., Novoyatleva, T., Wietelmann, A., Harriss, J., Ferrazzi, F., Böttger, T., Harvey, R.P., Tucker, P.W., et al. (2010). Cardiac deletion of Smyd2 is dispensable for mouse heart development. PLoS One 5, e9748.
20. Donlin, L.T., Andresen, C., Just, S., Rudensky, E., Pappas, C.T., Krüger, M., Jacobs, E.Y., Unger, A., Zieseniss, A., Dobenecker, M.W., et al. (2012). Smyd2 controls cytoplasmic lysine methylation of Hsp90 and myofilament organization. Genes Dev. 26, 114-119.
21. Ehler, E. and Gautel, M. (2008). The sarcomere and sarcomerogenesis. Adv. Exp. Med. Biol. 642, 1-14.
22. Fareed, M.U., Evenson, A.R., Wie, W., Menconi, M., Poylin, V., Petkova, V., Pignol, B., and Hasselgren, P.O. (2006). Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R1589-R1597.
23. Fischer, D., Matten, J., Reimann, J., Bönnemann, C., and Schröder, R. (2002). Expression, localization and functional divergence of alphaB-crystallin and heat shock protein 27 in core myopathies and neurogenic atrophy. Acta Neuropathol. 104, 297-304.
24. Freiburg, A., Trombitas, K., Hell, W., Cazorla, O., Fougerousse, F., Centner, T., Kolmerer, B., Witt, C., Beckmann, J.S., Gregorio, C.C., et al. (2000). Series of exon-skipping events in the elastic spring region of titin as the structural basis for myofibrillar elastic diversity. Circ. Res. 86, 1114-1121.
25. Frey, N., Richardson, J.A., and Olson, E.N. (2000). Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc. Natl. Acad. Sci. USA 97, 14632-14637.
26. Gao, C.Q., Sawicki, G., Suarez-Pinzon, W.L., Csont, T., Wozniak, M., Ferdinandy, P., and Schulz, R. (2003). Matrix metalloproteinase- 2 mediates cytokine-induced myocardial contractile dysfunction. Cardiovasc. Res. 57, 426-433.
27. Gautel, M. (2011). Cytoskeletal protein kinases: titin and its relations in mechanosensing. Pflüger's Arch. 462, 119-134.
28. Golenhofen, N., Htun, P., Ness, W., Koob, R., Schaper, W., and Drenckhahn, D. (1999). Binding of the stress protein alpha B-crystallin to cardiac myofibrils correlates with the degree of myocardial damage during ischemia/reperfusion in vivo. J. Mol. Cell. Cardiol. 31, 569-580.
29. Golenhofen, N., Arbeiter, A., Koob, R., and Drenckhahn, D. (2002). Ischemia-induced association of the stress protein alpha B-crystallin with I-band portion of cardiac titin. J. Mol. Cell. Cardiol. 34, 309-319.
30. Granzier, H.L. and Labeit, S. (2004). The giant protein titin: a major player in myocardial mechanics, signaling, and disease. Circ. Res. 94, 284-295.
31. Gräter, F., Shen, J., Jiang, H., Gautel, M., and Grubmuller, H. (2005). Mechanically induced titin kinase activation studied by forceprobe molecular dynamics simulations. Biophys. J. 88, 790-804.
32. Gregorio, C.C., Trombitás, K., Centner, T., Kolmerer, B., Stier, G., Kunke, K., Suzuki, K., Obermayr, F., Herrmann, B., Granzier, H., et al. (1998). The NH2 terminus of titin spans the Z-disc: its interaction with a novel 19-kD ligand (T-cap) is required for sarcomeric integrity. J. Cell Biol. 143, 1013-1027.
33. Gregorio, C.C., Perry, C.N., and McElhinny, A.S. (2005). Functional properties of the titin/connectin-associated proteins, the muscle-specific RING-finger proteins (MURFs), in striated muscle. J. Muscle Res. Cell Motil. 26, 389-400.
34. Guo, W., Schafer, S., Greaser, M.L., Radke, M.H., Liss, M., Govindarajan, T., Maatz, H., Schulz, H., Li, S., Parrish, A.M., et al. (2012). RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat. Med. 18, 766-773.
35. Hamdani, N., Bishu, K.G., von Frieling-Salewsky, M., Redfield, M.M., and Linke, W.A. (2013a). Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction. Cardiovasc. Res. 97, 464-471.
36. Hamdani, N., Krysiak, J., Kreusser, M.M., Neef, S., Dos Remedios, C.G., Maier, L.S., Krüger, M., Backs, J., and Linke, W.A. (2013b). Crucial role for Ca2(+)/calmodulin-dependent protein kinase-II in regulating diastolic stress of normal and failing hearts via titin phosphorylation. Circ. Res. 112, 664-674.
37. Hasselgren, P.O. and Fischer, J.E. (2001). Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation. Ann. Surg. 233, 9-17.
38. Hayashi, T., Arimura, T., Itoh-Satoh, M., Ueda, K., Hohda, S., Inagaki, N., Takahashi, M., Hori, H., Yasunami, M., Nishi, H., et al. (2004). Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J. Am. Coll. Cardiol. 44, 2192-2201.
39. Hayashi, C., Ono, Y., Doi, N., Kitamura, F., Tagami, M., Mineki, R., Arai, T., Taguchi, H., Yanagida, M., Hirner, S., et al. (2008). Multiple molecular interactions implicate the connectin/titin N2A region as a modulating scaffold for p94/calpain 3 activity in skeletal muscle. J. Biol. Chem. 283, 14801-14814.
40. Hein, S., Arnon, E., Kostin, S., Schönburg, M., Elsässer, A., Polyakova, V., Bauer, E.P., Klövekorn, W.P., and Schaper, J. (2003). Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107, 984-991.
41. Heineke, J., Ruetten, H., Willenbockel, C., Gross, S.C., Naguib, M., Schaefer, A., Kempf, T., Hilfiker-Kleiner, D., Caroni, P., Kraft, T., et al. (2005). Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-disc. Proc. Natl. Acad. Sci. USA 102, 1655-1660.
42. Herrmann, J., Ciechanover, A., Lerman, L.O., and Lerman, A. (2004). The ubiquitin-proteasome system in cardiovascular diseases - a hypothesis extended. Cardiovasc. Res. 61, 11-21.
43. Hidalgo, C., Hudson, B., Bogomolovas, J., Zhu, Y., Anderson, B., Greaser, M., Labeit, S., and Granzier, H. (2009). PKC phosphorylation of titin's PEVK element: a novel and conserved pathway for modulating myocardial stiffness. Circ. Res. 105, 631-638.
44. Hidalgo, C.G., Chung, C.S., Saripalli, C., Methawasin, M., Hutchinson, K.R., Tsaprailis, G., Labeit, S., Mattiazzi, A., and Granzier, H.L. (2013). The multifunctional Ca(2+)/calmodulin-dependent protein kinase II delta (CaMKIIä) phosphorylates cardiac titin's spring elements. J. Mol. Cell Cardiol. 54, 90-97.
45. Hojayev, B., Rothermel, B.A., Gillette, T.G., and Hill, J.A. (2012). FHL2 binds calcineurin and represses pathological cardiac growth. Mol. Cell Biol. 32, 4025-4034.
46. Horwitz, J. (2003). Alpha-crystallin. Exp. Eye. Res. 76, 145-153.
47. Hunter, J.J. and Chien, K.R. (1999). Signaling pathways for cardiac hypertrophy and failure. N. Engl. J. Med. 341, 1276-1283.
48. Kato, K., Shinohara, H., Kurobe, N., Inaguma, Y., Shimizu, K., and Ohshima, K. (1991). Tissue distribution and developmental profiles of immunoreactive alpha B crystallin in the rat determined with a sensitive immunoassay system. Biochim. Biophys. Acta. 1074, 201-208.
49. Knöll, R., Hoshijima, M., Hoffman, H.M., Person, V., Lorenzen- Schmidt, I., Bang, M.L., Hayashi, T., Shiga, N., Yasukawa, H., Schaper, W., et al. (2002). The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in asubset of human dilated cardiomyopathy. Cell 111, 943-955.
50. Knöll, R., Kostin, S., Klede, S., Savvatis, K., Klinge, L., Stehle, I., Gunkel, S., Kötter, S., Babicz, K., Sohns, M., et al. (2010). A common MLP (muscle LIM protein) variant is associated with cardiomyopathy. Circ. Res. 106, 695-704.
51. Knöll, R., Linke, W.A., Zou, P., Miocic, S., Kostin, S., Buyandelger, B., Ku, C.H., Neef, S., Bug, M., Schäfer, K., et al. (2011). Telethonin deficiency is associated with maladaptation to biomechanical stress in the mammalian heart. Circ. Res. 109, 758-769.
52. Kötter, S., Gout, L., von Frieling-Salewsky, M., Müller, A.E., Helling, S., Marcus, K., dos Remedios, C., Linke, W.A., and Krüger, M. (2013). Differential changes in titin domain phosphorylation increase myofilament stiffness in failing human hearts. Cardiovasc. Res. 99, 684-656.
53. Kötter, S., Unger, A., Hamdani, N., Lang, P., Vorgerd, M., Nagel- Steeger, L., and Linke, W.A. (2014). Human myozytes are protected from titin aggregation induced stiffening by small heat shock proteins. J. Cell Biol. 204, 187-202.
54. Krüger, M. and Linke, W.A. (2011). The giant protein titin: a regulatory node that integrates myocyte signalling pathways. J. Biol. Chem. 286, 9905-9912.
55. Krüger, M., Kohl, T., and Linke, W. A. (2006). Developmental changes in passive stiffness myofilament Ca2+ sensitivity due to titin and troponin-I isoform switching are not critically triggered by birth. Am. J. Physiol. Heart Circ. Physiol. 291, H496-H506.
56. Krüger, M., Kötter, S., Grützner, A., Lang, P., Andresen, C., Redfield, M.M., Butt, E., dos Remedios, C.G., and Linke, W.A. (2009). Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circ. Res. 104, 87-94.
57. Labeit, S., Lahmers, S., Burkart, C., Fong, C., McNabb, M., Witt, S., Witt, C., Labeit, D., and Granzier, H. (2006). Expression of distinct classes of titin isoforms in striated and smooth muscles by alternative splicing, and their conserved interaction with filamins. J. Mol. Biol. 362, 664-681.
58. Lange, S., Auerbach, D., McLoughlin, P., Perriard, E., Schäfer, B.W., Perriard, J.C., and Ehler, E. (2002). Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL2. J. Cell Sci. 115, 4925-4936.
59. Lange, S., Xiang, F., Yakovenko, A., Vihola, A., Hackman, P., Rostkova, E., Kristensen, J., Brandmeier, B., Franzen, G., Hedberg, B., et al. (2005). The kinase domain of titin controls muscle gene expression and protein turnover. Science 308, 1599-1603.
60. Lange, S., Ehler, E., and Gautel, M. (2006). From A to Z and back? Multicompartment proteins in the sarcomere. Trends Cell Biol. 16, 11-18.
61. Lanneau, D., Wettstein, G., Bonniaud, P., and Garrido, C. (2010). Heat shock proteins: cell protection through protein triage. ScientificWorldJournal 10, 1543-1552.
62. Li, H. and Fernandez, J.M. (2003). Mechanical design of the first proximal Ig domain of human cardiac titin revealed by single molecule force spectroscopy. J. Mol. Biol. 334, 75-86.
63. Li, H.B., Linke, W.A., Oberhauser, A.F., Carrion-Vazquez, M., Kerkviliet, J.G., Lu, H., Marszalek, P.E., and Fernandez, J.M. (2002). Reverse engineering of the giant muscle protein titin. Nature 418, 998-1002.
64. Li, J., Horak, K.M., Su, H., Sanbe, A., Robbins, J., and Wang, X. (2011). Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice. J. Clin. Invest. 121, 3689-3700.
65. Li, S., Guo, W., Dewey, C.N., and Greaser, M.L. (2013). Rbm20 regulates titin alternative splicing as a splicing repressor. Nucleic Acids Res. 41, 2659-2672.
66. Lim, D.S., Robers, R., and Marian, A.J. (2001). Expression profiling of cardiac genes in human hypertrophic cardiomyopathy. Insight into pathogenesis of phenotypes. J. Am. Coll. Cardiol. 38, 1175-1180.
67. Linke, W.A. and Hamdani, N. (2014). Gigantic business: titin properties and function through thick and thin. Circ. Res. 114, 1052-1068.
68. Linke, W.A. and Krüger, M. (2010). The giant protein titin as an integrator of myocyte signaling pathways. Physiology 25, 186-198.
69. Linke, W.A., Ivemeyer, M., Olivieri, N., Kolmerer, B., Rüegg, J.C., and Labeit, S. (1996). Towards a molecular understanding of the elasticity of titin. J. Mol. Biol. 261, 62-71.
70. Linke, W.A., Rudy, D.E., Centner, T., Gautel, M., Witt, C., Labeit, S., and Gregorio, C.C. (1999). I-band titin in cardiac muscle is a three-element molecular spring and is critical for maintaining thin filament structure. J. Cell Biol. 146, 631-644.
71. Liu, J., Tang, M., Mestril, R., and Wang, X. (2006). Aberrant protein aggregation is essential for a mutant desmin to impair the proteolytic function of the ubiquitin-proteasome system in cardiomyocytes. J. Mol. Cell. Cardiol. 40, 451-454.
72. Lutsch, G., Vetter, R., Offhauss, U., Wieske, M., Gröne, H.J., Klemenz, R., Schimke, I., Stahl, J., and Benndorf, R. (1997). Abundance and location of the small heat shock proteins HSP25 and alphaB-crystallin in rat and human heart. Circulation 96, 3466-3476.
73. Makarenko, I., Opitz, C.A., Leake, M.C., Neagoe, C., Kulke, M., Gwathmey, J.K., del Monte, F., Hajjar, R.J., and Linke, W.A. (2004). Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts. Circ. Res. 95, 708-716.
74. Mayans, O., van der Ven, P.F., Wilm, M., Mues, A., Young, P., Fürst, D.O., Wilmanns, M., and Gautel, M. (1998). Structural basis for activation of the titin kinase domain during myofibrillogenesis. Nature 395, 863-869.
75. McElhinny, A.S., Kakinuma, K., Sorimachi, H., Labeit, S., and Gregorio, C.C. (2002). Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1. J. Cell Biol. 157, 125-136.
76. Mchaourab, H.S., Berengian, A.R., and Koteiche, H.A. (1997). Site-directed spin-labeling study of the structure and subunit interactions along a conserved sequence in the alpha-crystallin domain of heatshock protein 27. Evidence of a conserved subunit interface. Biochemistry 36, 14627-14634.
77. McKenna, N., Meigs, J.B., and Wang, Y.L. (1985). Identical distribution of fluorescently labeled brain and muscle actins in living cardiac fibroblasts and myocytes. J. Cell Biol. 100, 292-296.
78. Mebratu, Y. and Tesfaigzi, Y. (2009). How ERK1/2 activation controls cell proliferationand cell death: is subcellular localization the answer? Cell Cycle 8, 1168-1175.
79. Meiners, S., Dreger, H., Fechner, M., Bieler, S., Rother, W., Günther, C., Baumann, G., Stangl, V., and Stangl, K. (2008). Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin- proteasome system. Hypertension 51, 302-308.
80. Miller, M.K., Granzier, H., Ehler, E., and Gregorio, C.C. (2004). The sensitive giant: the role of titin-based stretch sensing complexes in the heart. Trends Cell Biol. 14, 119-126.
81. Mittal, B., Sanger, J.M., and Sanger, J.W. (1987). Visualization of myosin in living cells. J. Cell Biol. 105, 1753-1760.
82. Moreira, E.S., Wiltshire, T.J., Faulkner, G., Nilforoushan, A., Vainzof, M., Suzuki, O.T., Valle, G., Reeves, R., Zatz, M., Passos-Bueno, M.R., et al. (2000). Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat. Genet. 24, 163-166.
83. Nagueh, S.F., Shah, G., Wu, Y., Torre-Amione, G., King, N.M., Lahmers, S., Witt, C.C., Becker, K., Labeit, S., and Granzier, H.L. (2004). Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy. Circulation 110, 155-162.
84. Neagoe, C., Kulke, M., del Monte, F., Gwathmey, J.K., de Tombe, P.P., Hajjar, R.J., and Linke, W.A. (2002). Titin isoform switch in ischemic human heart disease. Circulation 106, 1333-1341.
85. Neagoe, C., Opitz, C.A., Makarenko, I., and Linke, W.A. (2003). Gigantic variety: expression patterns of titin isoforms in striated muscles and consequences for myofibrillar passive stiffness. J. Muscle Res. Cell Motil. 24, 175-189.
86. Olson, E.N. and Williams, R.S. (2000). Calcineurin signaling and muscle remodeling. Cell 101, 689-692.
87. Opitz, C.A., Leake, M.C., Makarenko, I., Benes, V., and Linke, W.A. (2004). Developmentally regulated switching of titin size alters myofibrillar stiffness in the perinatal heart. Circ. Res. 94, 967-975.
88. Pankiv, S., Clausen, T.H., Lamark. T., Brech. A., Bruun. J.A., Outzen, H., Overvatn, A., Bjorkoy, G., and Johansen, T. (2007). p62/ SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiqzitinated protein aggregates by autophagy. J. Biol. Chem. 282, 24131-24145.
89. Paulsen, G., Lauritzen, F., Bayer, M.L., Kalhovde, J.M., Ugelstad, I., Owe, S.G., Hallén, J., Bergersen, L.H., and Raastad, T. (2009). Subcellular movement and expression of HSP27, áB-crystallin, and HSP70 after two bouts of eccentric exercise in humans. J. Appl. Physiol. 107, 570-582.
90. Pizon, V., Iakovenko, A., Van Der Ven, P.F., Kelly, R., Fatu, C., Fürst, D.O., Karsenti, E., and Gautel, M. (2002). Transient association of titin and myosin with microtubules in nascent myofibrils directed by the MURF2 RING-finger protein. J. Cell Sci. 115, 4469-4482.
91. Powell, S.R. and Divald, A. (2010). The ubiquitin-proteasome system in myocardial ischaemia and preconditioning. Cardiovasc. Res. 85, 303-311.
92. Prado, L.G., Makarenko, I., Andresen, C., Krüger, M., Opitz, C.A., and Linke, W.A. (2005). Isoform diversity of giant proteins in relation to passive and active contractile properties of rabbit skeletal muscles. J. Gen. Physiol. 126, 461-480.
93. Predmore, J.M., Wang, P., Davis, F., Bartolone, S., Westfall, M.V., Dyke, D.B., Pagani, F., Powell, S.R., and Day, S.M. (2010). Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies. Circulation 121, 997-1004.
94. Raskin, A., Lange, S., Banares, K., Lyon, R.C., Zieseniss, A., Lee, L.K., Yamazaki, K.G., Granzier, H.L., Gregorio, C.C., McCulloch, A.D., et al. (2012). A novel mechanism involving four-and-a half LIM domain protein-1 and extracellular signal-regulated kinase-2 regulates titin phosphorylation and mechanics. J. Biol. Chem. 287, 29273-29284.
95. Raynaud, F., Fernandez, E., Coulis, G., Aubry, L., Vignon, X., Bleimling, N., Gautel, M., Benyamin, Y., and Ouali, A. (2005). Calpain 1-titin interactions concentrate calpain 1 in the Z-band edges and in the N2-line region within the skeletal myofibril. FEBS Lett. 272, 2578-2590.
96. Razeghi, P., Baskin, K.K., Sharma, S., Young, M.E., Stepkowski, S., Essop, M.F., and Taegtmeyer, H. (2006). Atrophy, hypertrophy, and hypoxemia induce transcriptional regulators of the ubiquitin proteasome system in the rat heart. Biochem. Biophys. Res. Commun. 342, 361-364.
97. Rief, M., Gautel, M., Schemmel, A., and Gaub, H.E. (1998). The mechanical stability of immunoglobulin and fibronectin IIIdomains in the muscle protein titin measured by atomic force microscopy. Biophys. J. 75, 3008-3014.
98. Sanger, J.M., Mittal, B., Pochapin, M.B., and Sanger, J.W. (1986). Myofibrillogenesis in living cells microinjected with fluorescently labeled alpha-actinin. J. Cell Biol. 102, 2053-2066.
99. Sawicki, G., Leon, H., Sawicka, J., Sariahmetoglu, M., Schulze, C.J., Scott, P.G., Szczesna-Cordary, D., and Schulz, R. (2005). Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation 112, 544-552.
100. Schlossarek, S. and Carrier, L. (2011). The ubiquitin-proteasome system in cardiomyopathies. Curr. Opin. Cardiol. 26, 190-195.
101. Scholl, F.A., McLoughlin, P., Ehler, E., De Giovanni, C., and Schäfer, B.W. (2000). DRAL is a p53-responsive gene whose four-and-ahalf LIM domain protein product induces apoptosis. J. Cell Biol. 151, 495-506.
102. Seibenhener, M.L., Geetha, T., and Wooten, M.W. (2007). Sequestosome1/ p62 - more than just a scaffold. FEBS Lett. 581, 175-179.
103. Sheikh, F., Raskin, A., Chu, P.H., Lange, S., Domenighetti, A.A., Zheng, M., Liang, X., Zhang, T., Yajima, T., Gu, Y., et al. (2008). An FHL1-containing complex within the cardiomyocytesarcomere mediates hypertrophic biomechanical stress responses in mice. J. Clin. Invest. 118, 3870-3880.
104. Sung, M.M., Schulz, C.G., Wang, W., Sawicki, G., Bautista-Lopez, N.L., and Schulz, R. (2007). Matrix metalloproteinase-2 degrades the cytoskeletal protein á-actinin in peroxynitrite mediated myocardial injury. J. Mol. Cell Cardiol. 43, 429-436.
105. Tanoue, T., Adachi, M., Moriguchi, T., and Nishida, E. (2000). A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat. Cell Biol. 2, 110-116.
106. Trombitas, K., Greaser, M., Labeit, S., Jin, J.P., Kellermayer, M., Helmes, M., and Granzier, H. (1998). Titin extensibility in situ: entropic elasticity of permanently folded and permanently unfolded molecular segments. J. Cell Biol. 140, 853-859.
107. Tskhovrebova, L. and Trinick, J. (2004). Properties of titin immunoglobulin and fibronectin-3 domains. J. Biol. Chem. 279, 46351-46354.
108. Tskhovrebova, L. and Trinick, J. (2010). Roles of titin in the structure and elasticity of the sarcomere. J. Biomed. Biotechnol. 2010, 612482.
109. Tsukamoto, O., Minamino, T., Okada, K., Shintani, Y., Takashima, S., Kato, H., Liao, Y., Okazaki, H., Asai, M., Hirata, A., et al. (2006). Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice. Biochem. Biophys. Res. Commun. 340, 1125-1133.
110. van de Klundert, F.A., Gijsen, M.L., van den IJssel, P.R., Snoeckx, L.H., and de Jong, W.W. (1998). áB-crystallin and hsp25 in neonatal cardiac cells-differences in cellular localization under stress conditions. Eur. J. Cell Biol. 75, 38-45.
111. Voelkel, T., Andresen, C., Unger, A., Just, S., Rottbauer, W., and Linke, W.A. (2013). Lysine methyltransferase Smyd2 regulates Hsp90-mediated protection of the sarcomeric titin springs and cardiac function. Biochim. Biophys. Acta 1833, 812-822.
112. Vos, M.J., Hageman, J., Carra, S., and Kampinga, H.H. (2008). Structural and functional diversities between members of the human HSPB, HSPH, HSPA, and DNAJ chaperone families. Biochemistry 47, 7001-7011.
113. Wang, X. and Robbins, J. (2006). Heart failure and protein quality control. Circ Res. 99, 1315-1328.
114. Wang, W., Schulze, C.J., Suarez-Pinzon, W.L., Dyck, J.R., Sawicki, G., and Schulz, R. (2002). Intracellular action of matrix metalloproteinase- 2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 106, 1543-1549.
115. Watanabe, K., Muhle-Goll, C., Kellermayer, M.S.Z., Labeit, S., and Granzier, H. (2002). Different molecular mechanics displayed by titin's constitutively and differentially expressed tandem Ig segments. J. Struct. Biol. 137, 248-258.
116. Waters, S., Marchbank, K., Solomon, E., Whitehouse, C., and Gautel, M. (2009). Interactions with LC3 and polyubiquitin chains link nbr1 to autophagic protein turnover. FEBS Lett. 583, 1846-1852.
117. Watkins, S.J., Borthwick, G.M., and Arthur, H.M. (2011). The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cell Dev. Biol. Anim. 47, 125-131.
118. Weinert, S., Bergmann, N., Luo, X., Erdmann, B., and Gotthardt, M. (2006). M line-deficient titin causes cardiac lethality through impaired maturation of the sarcomere. J. Cell Biol. 173, 559-570.
119. Williams, A.B., Decourten-Myers, G.M., Fischer, J.E., Luo, G., Sun, X., and Hasselgren, P.O. (1999). Sepsis stimulates release of myofilaments in skeletal muscle by a calcium-dependent mechanism. FASEB J. 13, 1435-1443.
120. Witt, S.H., Granzier. H., Witt, C.C., and Labeit, S. (2005). MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination. J. Mol. Biol. 350, 713-722.
121. Witt, C.C., Burkart, C., Labeit, D., McNabb, M., Wu, Y., Granzier, H., and Labeit, S. (2006). Nebulin regulates thin filament length, contractility, and Z-disk structure in vivo. EMBO J. 25, 3843-3855.
122. Wohlschlaeger, J., Sixt, S.U., Stoeppler, T., Schmitz, K.J., Levkau, B., Tsagakis, K., Vahlhaus, C., Schmid, C., Peters, J., Schmid, K.W., et al. (2010). Ventricular unloading is associated with increased 20s proteasome protein expression in the myocardium. J. Heart Lung Transplant. 29, 125-132.
123. Yamasaki, R., Wu, Y., McNabb, M., Greaser, M., Labeit, S., and Granzier, H. (2002). Protein kinase A phosphorylates titin's cardiac-specific N2B domain and reduces passive tension in rat cardiac myocytes. Circ. Res. 90, 1181-1188.
124. Zhu, Y., Bogomolovas, J., Labeit, S., and Granzier, H. (2009). Single molecule force spectroscopy of the cardiac titin N2B element: effects of the molecular chaperone áB-crystallin with diseasecausing mutations. J. Biol. Chem. 284, 13914-13923.
125. Zou, P., Pinotsis, N., Lange, S., Song, Y.H., Popov, A., Mavridis, L., Mayans, O.M., Gautel, M., and Wilmanns, M. (2006). Palindromic assembly of the giant muscle protein titin in the sarcomeric Z-disk. Nature 439, 229-233.